- Home
- THRD vs NBH Comparison
THRD vs NBH Comparison
Compare THRD & NBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THRD
- NBH
- Stock Information
- Founded
- THRD 2019
- NBH 2002
- Country
- THRD United States
- NBH United States
- Employees
- THRD N/A
- NBH N/A
- Industry
- THRD Biotechnology: Pharmaceutical Preparations
- NBH Finance/Investors Services
- Sector
- THRD Health Care
- NBH Finance
- Exchange
- THRD Nasdaq
- NBH Nasdaq
- Market Cap
- THRD 335.2M
- NBH 300.6M
- IPO Year
- THRD 2022
- NBH N/A
- Fundamental
- Price
- THRD $6.00
- NBH $10.50
- Analyst Decision
- THRD Strong Buy
- NBH
- Analyst Count
- THRD 3
- NBH 0
- Target Price
- THRD $20.33
- NBH N/A
- AVG Volume (30 Days)
- THRD 248.2K
- NBH 85.9K
- Earning Date
- THRD 11-07-2024
- NBH 01-01-0001
- Dividend Yield
- THRD N/A
- NBH 4.34%
- EPS Growth
- THRD N/A
- NBH N/A
- EPS
- THRD N/A
- NBH 0.12
- Revenue
- THRD N/A
- NBH N/A
- Revenue This Year
- THRD N/A
- NBH N/A
- Revenue Next Year
- THRD N/A
- NBH N/A
- P/E Ratio
- THRD N/A
- NBH $87.04
- Revenue Growth
- THRD N/A
- NBH N/A
- 52 Week Low
- THRD $5.60
- NBH $8.75
- 52 Week High
- THRD $16.94
- NBH $11.01
- Technical
- Relative Strength Index (RSI)
- THRD 23.75
- NBH 55.79
- Support Level
- THRD $5.60
- NBH $10.11
- Resistance Level
- THRD $11.78
- NBH $10.45
- Average True Range (ATR)
- THRD 0.89
- NBH 0.10
- MACD
- THRD -0.43
- NBH 0.04
- Stochastic Oscillator
- THRD 6.50
- NBH 100.00
About THRD Third Harmonic Bio Inc.
Third Harmonic Bio Inc is a biopharmaceutical company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. Its other product candidate THB335, is a potent, selective, oral small molecule KIT inhibitor, for the treatment of multiple mast cell-driven inflammatory diseases of the skin, airway, and gastrointestinal tract.
About NBH Neuberger Berman Municipal Fund Inc.
Neuberger Berman Intermediate Muni Fund is a closed-end management investment company that invests mainly in municipal securities. It aims to provide common stockholders a high level of current income exempt from Federal income tax.